06/20/2024
3:31 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:33 PM | Allogene Therapeutics (Subject)
MESSEMER DEBORAH M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:30 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:28 PM | Allogene Therapeutics (Issuer)
Kazam Joshua A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:29 PM | Allogene Therapeutics (Issuer)
WITTE OWEN N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:30 PM | Allogene Therapeutics (Issuer)
Humer Franz B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:33 PM | Allogene Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/07/2024
4:34 PM | Allogene Therapeutics (Issuer)
Barrett Elizabeth A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:35 PM | Allogene Therapeutics (Issuer)
Mayo Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:25 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:09 PM | Allogene Therapeutics (Issuer)
Humer Franz B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
1:08 PM | Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
8:33 PM | Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:01 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:02 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:38 PM | Allogene Therapeutics (Filer)
| Form 424B5 | |
05/14/2024
3:40 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:02 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
11:15 PM | Allogene Therapeutics (Filer)
| Form EFFECT | |
04/24/2024
3:18 PM | Allogene Therapeutics (Issuer)
MOORE TIMOTHY L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:31 PM | Allogene Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024
3:32 PM | Allogene Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024
3:33 PM | Allogene Therapeutics (Filer)
| Form ARS | |
04/22/2024
3:09 PM | Allogene Therapeutics (Subject)
MOORE TIMOTHY L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
7:10 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
4:28 PM | Allogene Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/14/2024
4:21 PM | Allogene Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/14/2024
3:51 PM | Allogene Therapeutics (Filer)
| Form POSASR | |
03/14/2024
3:55 PM | Allogene Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
3:31 PM | Allogene Therapeutics (Subject)
Chang David D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
8:52 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
7:30 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:36 PM | Allogene Therapeutics (Subject)
Belldegrun Arie (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Allogene Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
4:45 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:46 PM | Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:47 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:48 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:51 PM | Allogene Therapeutics (Issuer)
MOORE TIMOTHY L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:42 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | Allogene Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
The death of Nvidia? (Ad) Today, I’m warning of another looming catastrophe.
Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out.
You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy...
There's also no escaping that The Big AI Die-Up is coming. So go here now to read my new report The Big AI Die-Up… while you still can. |
01/24/2024
4:25 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
9:02 AM | Allogene Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
3:11 PM | Allogene Therapeutics (Subject)
Roberts Zachary (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:00 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:26 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
2:46 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:17 PM | Allogene Therapeutics (Subject)
MESSEMER DEBORAH M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:41 PM | Allogene Therapeutics (Filer)
| Form 424B5 | |
10/25/2023
4:29 PM | Allogene Therapeutics (Subject)
PFIZER INC (Filed by)
| Form SC 13D/A | |
10/17/2023
3:34 PM | Allogene Therapeutics (Filer)
| Form 8-K/A | |
10/16/2023
6:25 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
7:31 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
